Automated description from the Alliance of Genome Resources (Release 7.3.0)
Predicted to enable Wnt-protein binding activity; activin receptor binding activity; and nodal binding activity. Acts upstream of or within positive regulation of fat cell differentiation. Predicted to be active in cell surface and extracellular region. Is expressed in several structures, including alimentary system; genitourinary system; limb; nervous system; and sensory organ. Human ortholog(s) of this gene implicated in breast cancer; renal cell carcinoma; and urinary bladder cancer. Orthologous to human WIF1 (WNT inhibitory factor 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.